Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $53.85 USD
Change Today -1.52 / -2.75%
Volume 12.9M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 8:04 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael Rosenblatt M.D.

Chief Medical Officer and Executive Vice President,Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 2 different organizations across 10 different industries.

See Board Relationships
67--

Background*

Dr. Michael Rosenblatt, M.D., has been Chief Medical Officer, Executive Vice President and Head of Global Center for Scientific Affairs at Merck & Co. Inc. since December 16, 2009. He co-founded Theracrine, Inc. in 2010. He also co-Founded Radius Health, Inc. and serves as its Board Observer. Dr. Rosenblatt was an Advisor at PureTech Ventures. Dr. Rosenblatt’s research is in the field of hormonal regulation of calcium metabolism, osteoporosis and cancer metastasis to ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
Harvard University
BA
Columbia University
MD
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $53.85 USD -1.52

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.